Actively Recruiting
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
Led by University of Pittsburgh · Updated on 2025-12-15
218
Participants Needed
1
Research Sites
77 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to assess whether a liberal intrapartum glycemic target range compared to usual care standard control ranges will lead to a decrease in the rate of neonatal hypoglycemia among pregnant patients in labor with diabetes.
CONDITIONS
Official Title
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant patients with Pre-gestational (Type 1 or Type 2) or Gestational Diabetes
- Singleton Gestations
- Greater than or equal to 35 weeks gestation
- Planned for vaginal delivery at the University of Pittsburgh Medical Center Magee-Womens Hospital (UPMC MWH)
You will not qualify if you...
- Major fetal anomalies anticipated to require NICU admission
- Planned Cesarean delivery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Magee-Women's Hospital of UPMC
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
Research Team
P
Praveen Ramesh, M.D.
CONTACT
M
Maisa Feghali, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here